Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCND3 antisense RNA 1 (KCND3-AS1)
- Target
- KCND3-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), Antisense RNA
01
Overview
KCND3 antisense RNA 1 (KCND3-AS1) is a long noncoding RNA located in close proximity to and transcribed antisense to the KCND3 gene, which encodes a subunit of a voltage-gated potassium channel critical in cardiac and neuronal electrical activity. KCND3-AS1 is thought to modulate KCND3 expression through mechanisms typical of lncRNAs, such as chromatin remodeling and influencing transcription and post-transcriptional processes. While its specific physiological functions are not fully described, genetic studies implicate this locus, including KCND3-AS1, in cardiovascular electrical properties and arrhythmia susceptibility, suggesting a potential role in gene regulatory networks affecting heart electrophysiology. There is no evidence establishing it as a drug target, diagnostic biomarker, or direct participant in known disease mechanisms outside its regulatory influence in the KCND3 genetic locus.
- Other names
- KCND3-AS1KCND3 antisense RNA 1 (non-protein coding)
02
Mechanism of action
Not applicable. No drugs targeting KCND3-AS1 or established mechanisms of therapeutic modulation.
03
Biological functions
Regulation of gene expression (particularly KCND3, a potassium channel gene)Epigenetic regulation (lncRNAs commonly modulate chromatin state, transcription initiation, and post-transcriptional processing)
04
Disease associations
Cardiovascular disease (associated locus near KCND3 linked to electrophysiological risk via gene regulation, with KCND3-AS1 suggested as a regulatory element)Potential broader disease roles by analogy to other lncRNAs, though no direct evidence for KCND3-AS1 in cancer or other diseases was found in current sources
Beyond the preview
Go deeper on KCND3 antisense RNA 1 (KCND3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KCND3 antisense RNA 1 (KCND3-AS1).